Ok_老虎社区_美港股上老虎

lilykoh
2021-11-18

Novavax shares jumped 5% in premarket trading<blockquote>Novavax股价在盘前交易中上涨5%</blockquote>

Novavax shares jumped 5% in premarket trading as EU decision on Novavax COVID-19 shot could come 'wi

Novavax shares jumped 5% in premarket trading<blockquote>Novavax股价在盘前交易中上涨5%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":878700983,"tweetId":"878700983","gmtCreate":1637227406411,"gmtModify":1637227406556,"author":{"id":4093934996011550,"idStr":"4093934996011550","authorId":4093934996011550,"authorIdStr":"4093934996011550","name":"lilykoh","avatar":"https://static.tigerbbs.com/5e693f1d8cedc3c169cb20a422580f48","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":8,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/878700983","repostId":1168434077,"repostType":4,"repost":{"id":"1168434077","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637227046,"share":"https://www.laohu8.com/m/news/1168434077?lang=zh_CN&edition=full","pubTime":"2021-11-18 17:17","market":"us","language":"en","title":"Novavax shares jumped 5% in premarket trading<blockquote>Novavax股价在盘前交易中上涨5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168434077","media":"Tiger Newspress","summary":"Novavax shares jumped 5% in premarket trading as EU decision on Novavax COVID-19 shot could come 'wi","content":"<p>Novavax shares jumped 5% in premarket trading&nbsp;as&nbsp;EU decision on Novavax COVID-19 shot could come 'within weeks'.</p><p><blockquote>由于欧盟可能在“几周内”就Novavax COVID-19疫苗做出决定，Novavax股价在盘前交易中上涨5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6082341ff6cf8c02e6284028a5ba5cd6\" tg-width=\"848\" tg-height=\"620\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The European Union’s drug regulator said on Wednesday it could decide on Novavax’s COVID-19 vaccine approval “within weeks” if the data it has received from the drugmaker was sufficient to prove the shot’s effectiveness.</p><p><blockquote>欧盟药品监管机构周三表示，如果从制药商那里收到的数据足以证明疫苗的有效性，它可能会在“几周内”决定批准Novavax的COVID-19疫苗。</blockquote></p><p> The protein-based vaccine, branded Nuvaxovid, has been under a rolling review since February, the European Medicines Agency (EMA) said. Such reviews allow for a speedy approval.</p><p><blockquote>欧洲药品管理局(EMA)表示，这种名为Nuvaxovid的蛋白质疫苗自2月份以来一直在接受滚动审查。这种审查允许快速批准。</blockquote></p><p> If approved by the EMA, the shot would be the region’s fifth coronavirus vaccine, joining those from Pfizer-BioNTech, Moderna, AstraZeneca and Johnson &amp; Johnson.</p><p><blockquote>如果获得EMA批准，该疫苗将成为该地区的第五种冠状病毒疫苗，加入辉瑞-BioNTech、Moderna、阿斯利康和强生公司的行列。</blockquote></p><p> The major approval could come much ahead of authorisation in the United States, where Novavax had to resolve manufacturing issues and expects to file for approval by the end of the year.</p><p><blockquote>重大批准可能会远远早于美国的授权，Novavax必须在美国解决制造问题，并预计在今年年底前申请批准。</blockquote></p><p> The EMA said two of its advisory panels were looking into various plans submitted by Novavax on risk management, and development and studies of the vaccine for use in children.</p><p><blockquote>EMA表示，其两个顾问小组正在研究Novavax提交的关于风险管理以及儿童疫苗开发和研究的各种计划。</blockquote></p><p> Novavax’s shot received its first emergency use approval earlier this month in Indonesia. The company has also sought backing from the World Health Organization. The Philippines on Wednesday authorised emergency use of a version made by India’s Serum Institute.</p><p><blockquote>Novavax的疫苗本月早些时候在印度尼西亚获得了首次紧急使用批准。该公司还寻求世界卫生组织的支持。菲律宾周三授权紧急使用印度血清研究所制造的版本。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped 5% in premarket trading<blockquote>Novavax股价在盘前交易中上涨5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped 5% in premarket trading<blockquote>Novavax股价在盘前交易中上涨5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-18 17:17</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares jumped 5% in premarket trading&nbsp;as&nbsp;EU decision on Novavax COVID-19 shot could come 'within weeks'.</p><p><blockquote>由于欧盟可能在“几周内”就Novavax COVID-19疫苗做出决定，Novavax股价在盘前交易中上涨5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6082341ff6cf8c02e6284028a5ba5cd6\" tg-width=\"848\" tg-height=\"620\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The European Union’s drug regulator said on Wednesday it could decide on Novavax’s COVID-19 vaccine approval “within weeks” if the data it has received from the drugmaker was sufficient to prove the shot’s effectiveness.</p><p><blockquote>欧盟药品监管机构周三表示，如果从制药商那里收到的数据足以证明疫苗的有效性，它可能会在“几周内”决定批准Novavax的COVID-19疫苗。</blockquote></p><p> The protein-based vaccine, branded Nuvaxovid, has been under a rolling review since February, the European Medicines Agency (EMA) said. Such reviews allow for a speedy approval.</p><p><blockquote>欧洲药品管理局(EMA)表示，这种名为Nuvaxovid的蛋白质疫苗自2月份以来一直在接受滚动审查。这种审查允许快速批准。</blockquote></p><p> If approved by the EMA, the shot would be the region’s fifth coronavirus vaccine, joining those from Pfizer-BioNTech, Moderna, AstraZeneca and Johnson &amp; Johnson.</p><p><blockquote>如果获得EMA批准，该疫苗将成为该地区的第五种冠状病毒疫苗，加入辉瑞-BioNTech、Moderna、阿斯利康和强生公司的行列。</blockquote></p><p> The major approval could come much ahead of authorisation in the United States, where Novavax had to resolve manufacturing issues and expects to file for approval by the end of the year.</p><p><blockquote>重大批准可能会远远早于美国的授权，Novavax必须在美国解决制造问题，并预计在今年年底前申请批准。</blockquote></p><p> The EMA said two of its advisory panels were looking into various plans submitted by Novavax on risk management, and development and studies of the vaccine for use in children.</p><p><blockquote>EMA表示，其两个顾问小组正在研究Novavax提交的关于风险管理以及儿童疫苗开发和研究的各种计划。</blockquote></p><p> Novavax’s shot received its first emergency use approval earlier this month in Indonesia. The company has also sought backing from the World Health Organization. The Philippines on Wednesday authorised emergency use of a version made by India’s Serum Institute.</p><p><blockquote>Novavax的疫苗本月早些时候在印度尼西亚获得了首次紧急使用批准。该公司还寻求世界卫生组织的支持。菲律宾周三授权紧急使用印度血清研究所制造的版本。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168434077","content_text":"Novavax shares jumped 5% in premarket trading as EU decision on Novavax COVID-19 shot could come 'within weeks'.\n\nThe European Union’s drug regulator said on Wednesday it could decide on Novavax’s COVID-19 vaccine approval “within weeks” if the data it has received from the drugmaker was sufficient to prove the shot’s effectiveness.\nThe protein-based vaccine, branded Nuvaxovid, has been under a rolling review since February, the European Medicines Agency (EMA) said. Such reviews allow for a speedy approval.\nIf approved by the EMA, the shot would be the region’s fifth coronavirus vaccine, joining those from Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson.\nThe major approval could come much ahead of authorisation in the United States, where Novavax had to resolve manufacturing issues and expects to file for approval by the end of the year.\nThe EMA said two of its advisory panels were looking into various plans submitted by Novavax on risk management, and development and studies of the vaccine for use in children.\nNovavax’s shot received its first emergency use approval earlier this month in Indonesia. The company has also sought backing from the World Health Organization. The Philippines on Wednesday authorised emergency use of a version made by India’s Serum Institute.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1897,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}